abnormal pancreatic excretion of 5,5-dimethyl-2,4-oxazolidinedione ( dmo ) was demonstrated in 44 patients with chronic pancreatitis ( 14 with calcification and 30 without calcification ) .
C0030274
pancreatic
C0149521
chronic pancreatitis